This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Researchers Turn Big Data Problems Into Advanced Biology And Drug Discoveries

SGI (NASDAQ:SGI), the trusted leader in technical computing, today announced that researchers in the compute-intensive field of biotechnology research are continuing to make breakthrough progress with their selection of the SGI® UV™ high performance computing (HPC) system. SGI UV is the leading scalable shared memory architecture in the industry today, and is being deployed to tackle many of the world’s most difficult and complex compute challenges. The Center for Pharmaceutical Biotechnology, University of Illinois at Chicago (UIC) and The Genome Analysis Centre (TGAC) in the UK are two examples.

Researchers at the Center for Pharmaceutical Biotechnology at UIC are working on the development of new therapeutics focused on the treatment of infectious diseases, critical with the advent of new resistant bacterial strains and ineffective treatments for many diseases. The discovery of novel chemical compounds that form the basis for the development of molecular scaffolds of new antimicrobials is a daunting task. One promising approach is the use of diverse chemical compound libraries—thousands of chemical compounds—that are tested against unique targets to find effective inhibitors of bacterial growth. The approach is promising, but can be extremely time-consuming, expensive and resource-intensive.

A parallel approach is the virtual screening of chemical compounds against these unique targets since their three-dimensional structures have been determined. After a virtual library of molecules is screened, they are ranked. Literally millions of molecules can be screened in this fashion, and used to generate a smaller library of molecules for testing. This virtual—or in silico—screening requires the use of hundreds of processors working in parallel to screen millions of compounds in a timely manner.

“Researchers at the Center have been using SGI IRIX® OS-based clusters for the past decade, and have now migrated to an SGI UV high performance compute solution powered by large arrays of Intel® Xeon® series processors and NVIDIA® Tesla® series GPUs,” said Michael E. Johnson, professor and director emeritus at the Center for Pharmaceutical Biotechnology at UIC. “These clusters provide computing flexibility in managing both serial and parallel calculations, and the forward compatibility of SGI systems have allowed us to seamlessly evolve and expand our computing power through the years and keep up with the increasing complexity of the problems we need to address.”

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,265.99 +109.14 0.64%
S&P 500 2,011.36 +9.79 0.49%
NASDAQ 4,593.4250 +31.2360 0.68%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs